Tungsten-induced carcinogenesis in human bronchial epithelial cells

Toxicology and Applied Pharmacology

Volumn 288, Issue 1, 2015, Pages 33-39

  Laulicht, Freda ^a   Brocato, Jason ^a   Cartularo, Laura ^a   Vaughan, Joshua ^a   Wu, Feng ^a   Kluz, Thomas ^a   Sun, Hong ^a   Oksuz, Betul Akgol ^a   Shen, Steven ^a   Paena, Massimilano ^b   Medici, Serenella ^b   Zoroddu, Maria Antonietta ^b   Costa, Max ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Beas 2B; Cancer; In vitro; Nude mice; RNA Seq; Tungsten

Indexed keywords

ALPHA CRYSTALLIN; CALVASCULIN; CD74 ANTIGEN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 3; CRYSTALLIN ALPHA B; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HOMEOBOX 5; HOMEODOMAIN PROTEIN; PROTEIN SERINE THREONINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); S PHASE KINASE ASSOCIATED PROTEIN 2; SERINE THREONINE PROTEIN KINASE 26; TRANSFORMING GROWTH FACTOR BETA1; TUNGSTEN; UNCLASSIFIED DRUG; TUNGSTATE; TUNGSTEN DERIVATIVE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL MODEL; ARTICLE; BRONCHUS CANCER; BRONCHUS MUCOSA; CANCER GROWTH; CELL CLONE; CELL MIGRATION; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; NUDE MOUSE; RNA SEQUENCE; TUMOR GENE; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BRONCHUS; CANCER TRANSPLANTATION; CELL LINE; CELL MOTION; CELL PROLIFERATION; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TIME; TUMOR VOLUME; XENOGRAFT;

MUS MUSCULUS;

ANIMALS; BRONCHI; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MICE, NUDE; NEOPLASM TRANSPLANTATION; TIME FACTORS; TUMOR BURDEN; TUNGSTEN COMPOUNDS;

EID: 84937064583     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.07.003     Document Type: Article

References (41)

1. Adamakis I.D.S., et al. Tungsten toxicity in plants. Plants 2012, 1(2):82-89.
2. Archer S.Y., et al. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(12):6791-6796.
3. Arita A., et al. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009, 1(3):222-228.
4. Association of State and Territorial Solid Waste Management Officials, ASTSWMO Tungsten Issues Paper 2011.
5. Bey E.A., et al. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(28):11832-11837.
6. Brocato J., et al. Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis. Crit. Rev. Toxicol. 2013, 43(6):493-514.
7. Butrym A., et al. High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients. Med. Oncol. 2013, 30(2):560.
8. Cai L., et al. An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting. Mol. Cell 2013, 49(3):571-582.
9. Chakraborty A., et al. Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood 1996, 88(7):2442-2449.
10. Chen G., et al. Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines. Blood 2007, 109(12):5301-5307.
11. Chen H., et al. Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells. Carcinogenesis 2010, 31(12):2136-2144.
12. Clancy H.A., et al. Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer. Metallomics 2012, 4:784-793.
13. Clausen J.L., et al. Fate and Transport of Tungsten at Camp Edwards Small Arms Ranges. ERDC TR-07-05 2007, Strategic Environmental Research and Development Program. U.S. Army Corps of Engineers Engineer Research and Development Center.
14. Cohen J., et al. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cancer Res. 2009, 69(8):3415-3424.
15. Hata T., et al. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Mol. Cancer Ther. 2005, 10:1585-1594.
16. Hattori H., et al. RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells. Blood 2007, 110(2):640-650.
17. Hayes R.B. The carcinogenicity of metals in humans. Cancer Causes Control 1997, 8(3):371-385.
18. Iskander K., et al. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease. Cancer Res. 2008, 68(19):7915-7922.
19. Knaus P.I., et al. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol. 1996, 16(7):3480-3489.
20. Kumtepe Y., et al. High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker. Eur. J. Med. Res. 2013, 18(18).
21. Lin J.L., et al. MST4, a new Ste20-related kinase that mediates cell growth and transformation via modulating ERK pathway. Oncogene 2001, 20(45):6559-6569.
22. Liu H.C., et al. Expression of HOXB genes is significantly different in acute myeloid leukemia with a partial tandem duplication of MLL vs. a MLL translocation: a cross-laboratory study. Cancer Genet. 2011, 204(5):252-259.
23. Love M.I., et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15:550.
24. Lu H., et al. Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth. Ann. Hematol. 2014, 93(3):485-492.
25. Meo S.A., et al. Health hazards of welding fumes. Saudi Med. J. 2003, 24(11):1176-1182.
26. Moffatt K.A., et al. Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res. 2001, 61(19):7122-7129.
27. Morgan M., et al. ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics 2009, 25(19):2607-2608.
28. Naaman C., et al. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 2004, 23(20):3670-3680.
29. Nakagawa M., et al. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J. Biol. Chem. 2005, 280(40):33926-33934.
30. Oshlack A., et al. From RNA-seq reads to differential expression results. Genome Biol. 2010, 11:220.
31. Qin H., et al. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer. Med. Oncol. 2014, 8(142).
32. Robinson M.D., et al. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26(1):139-140.
33. Sato J.D., Kan M. Media for culture of mammalian cells. Curr. Protoc. Cell Biol. 2001, 1(2):1.2.1-1.2.15.
34. Sun H., et al. Comparison of gene expression profiles in chromate transformed BEAS-2B cells. PLoS One 2011, 6:e17982. 10.1371/journal.pone.0017982.
35. Thompson A., et al. Global down-regulation of HOX gene expression in PML-RARalpha+acute promyelocytic leukemia identified by small-array real-time PCR. Blood 2003, 101(4):1558-1565.
36. Turley J.M., et al. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. Cell Growth Differ. 1996, 7(11):1535-1544.
37. Tyrrell J., Galloway T.S., Abo-Zaid G., Melzer D., Depledge M.H., Osborne N.J. High urinary tungsten concentration is associated with stroke in the National Health and Nutrition Examination Survey 1999-2010. PLoS One 2013, 8:1-7.
38. Wiencke J.K., et al. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol. Biomarkers Prev. 1997, 6(2):87-92.
39. Wild P., et al. Lung cancer and exposure to metals: the epidemiological evidence. Methods Mol. Biol. 2009, 472:139-167.
40. Yamaguchi T., et al. The role of STAT3 in granulocyte colony-stimulating factor-induced enhancement of neutrophilic differentiation of Me2SO-treated HL-60 cells. GM-CSF inhibits the nuclear translocation of tyrosine-phosphorylated STAT3. J. Biol. Chem. 1999, 274(22):15575-15581.
41. Yokoi S., et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am. J. Pathol. 2002, 161(1):207-216.